Theseus Pharmaceuticals I... (THRX)
NASDAQ: THRX
· Real-Time Price · USD
4.07
0.01 (0.25%)
At close: Feb 13, 2024, 9:59 PM
Theseus Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -56.61M | -57.85M | -54.7M | -50.61M | -45.55M | -38.17M | -33.33M | -27.31M | -21.54M | -15.6M | -8.79M |
Depreciation & Amortization | 83K | 79K | 69K | 50K | 31K | 13K | 2K | 2K | 1K | 2K | 2K |
Stock-Based Compensation | 12.58M | 13.42M | 12.36M | 11.41M | 10.62M | 7.44M | 5.86M | 4.36M | 3.56M | 2.3M | 1.36M |
Other Working Capital | 4.97M | 6.02M | 4.87M | 2.58M | 2.13M | -161K | -2.44M | -4.1M | -2.22M | -2.27M | -1.02M |
Other Non-Cash Items | -712K | -654K | -788K | -350K | -4.24M | -4.49M | -4.41M | -4.25M | -1K | -1K | -1K |
Deferred Income Tax | -2.98M | -1.24M | n/a | n/a | 4.25M | 4.25M | 4.25M | 4.25M | n/a | n/a | n/a |
Change in Working Capital | -2M | 422K | -836K | 6.55M | 1.96M | -54K | -2.04M | -4.25M | -536K | -1.13M | -247K |
Operating Cash Flow | -49.63M | -45.83M | -43.89M | -32.95M | -32.92M | -31.02M | -29.68M | -27.19M | -18.52M | -14.43M | -7.67M |
Capital Expenditures | -61K | -74K | -417K | -455K | -432K | -369K | -15K | 12K | n/a | n/a | n/a |
Cash Acquisitions | 166.95M | 117.35M | 117.29M | 117.29M | -49.6M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -185.81M | -238.02M | -157.41M | -191.44M | -155.32M | -93.48M | -90.67M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 117.12M | 146.97M | 115.48M | 74.6M | 49.6M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -166.96M | -117.36M | -117.31M | -117.29M | 49.6M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -68.76M | -91.14M | -42.36M | -117.29M | -106.15M | -93.85M | -90.69M | 12K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 49.74M | 49.74M | 49.67M | 182K | 164.24M | 162.76M | 163.88M | 263.78M | 103.6M | 110.08M | 108.89M |
Financial Cash Flow | 49.63M | 49.63M | 49.49M | 182.00 | 164.17M | 162.69M | 163.88M | 263.78M | 103.6M | 110.08M | 108.89M |
Net Cash Flow | -68.65M | -87.23M | -36.58M | -150.06M | 25.16M | 37.88M | 43.51M | 236.58M | 85.08M | 95.65M | 101.21M |
Free Cash Flow | -49.69M | -45.91M | -44.31M | -33.4M | -33.35M | -31.39M | -29.69M | -27.18M | -18.52M | -14.43M | -7.67M |